Botulinum toxin as novel treatment for excess mucous membrane graft secretions.
Salivary gland secretion is an unusual complication of mucous membrane grafting. The authors report a case in which botulinum toxin was successfully used to treat graft secretions after buccal mucous membrane autograft for recurrent pterygium repair.
Ranchod
Tushar M
TM
Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Wu
Wayne W
WW
Gausas
Roberta E
RE
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D003228:Conjunctiva / Q000601:surgery*; D006801:Humans; D008297:Male; D009061:Mouth Mucosa / Q000378:metabolism / Q000637:transplantation*; D009498:Neurotoxins / Q000627:therapeutic use*; D011625:Pterygium / Q000601:surgery*; D012008:Recurrence; D012798:Sialorrhea / Q000188:drug therapy*; D014182:Transplantation, Autologous
D009498:Neurotoxins; D019274:Botulinum Toxins, Type A